Ultrasonic treatment of glaucoma

Surgery: kinesitherapy – Kinesitherapy – Ultrasonic

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C606S027000, C606S028000

Reexamination Certificate

active

07909781

ABSTRACT:
A method of treating glaucoma is described herein. The method includes the steps of providing an ultrasonic device that emits ultrasonic energy, holding the ultrasonic instrument at a location external to the trabecular meshwork, transmitting the ultrasonic energy at a frequency to a desired location for a predetermined time, dislodging material built up in the trabecular meshwork, and generating heat that initiates biochemical changes in the eye.

REFERENCES:
patent: 4350917 (1982-09-01), Lizzi
patent: 4484569 (1984-11-01), Driller
patent: 4531934 (1985-07-01), Kossovsky
patent: 4561019 (1985-12-01), Lizzi
patent: 4729373 (1988-03-01), Peyman
patent: 4858124 (1989-08-01), Lizzi
patent: 5080101 (1992-01-01), Dory
patent: 5209221 (1993-05-01), Riedlinger
patent: 5458130 (1995-10-01), Kaufman
patent: 6039689 (2000-03-01), Lizzi
patent: 6162193 (2000-12-01), Ekberg
patent: 6352519 (2002-03-01), Anis et al.
patent: 6416740 (2002-07-01), Unger
patent: 6433464 (2002-08-01), Jones
patent: 6652459 (2003-11-01), Payne
patent: 6679855 (2004-01-01), Horn
patent: 6685657 (2004-02-01), Jones
patent: 6764439 (2004-07-01), Schaaf
patent: 6979328 (2005-12-01), Baerveldt
patent: 7094225 (2006-08-01), Tu
patent: 2002/0111608 (2002-08-01), Baerveldt
patent: 2003/0088260 (2003-05-01), Smedley
patent: 2003/0097151 (2003-05-01), Smedley et al.
patent: 2004/0030269 (2004-02-01), Horn
patent: 2004/0091541 (2004-05-01), Unger
patent: 2006/0047263 (2006-03-01), Tu et al.
patent: 2006/0106370 (2006-05-01), Baerveldt
patent: 2006/0106424 (2006-05-01), Bachem
patent: 2006/0173437 (2006-08-01), Robin
patent: 2006/0217741 (2006-09-01), Ghannoum
patent: 2631545 (1989-11-01), None
patent: WO2006/021651 (2006-03-01), None
Extended European Search Report dated Sep. 10, 2009, which includes the supplementary European search report and the European search opinion, for related European Application No. 07814316.1.
Alexander JP, Acott TS; Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs; Invest Ophthalmol Vis Sci. Nov. 2001; 42(12):2831-8.
Fleenor DL, Pang IH, Clark AF; Involvement of AP-1 in interleukin-1alpha-stimulated MMP-3 expression in human trabecular meshwork cells; Invest Ophthalmol Vis Sci. Aug. 2003;44(8):3494-501.
Office Action issued on May 25, 2010, by Chinese Intellectual Property Office in related Chinese Patent Application No. 200780035161.2.
Cellular Tolerance to Pulsed Hyperthermia, by D. M. Simanovskii, et al., Physical Review, Jul. 24, 2006.
Effect of Ultraviolet Irradiation Upon the Cutaneous Pain Threshold, by M. Lipkin, et al., Journal of Applied Physiology May 1955 vol. 7 No. 6; pp. 683-687.
“Cytokine induction by 41.8° C whole body hyperthermia ‘WBH,’” by H. Ian Robins, et al., Cancer Letters, vol. 97, Issue 2, Nov. 6, 1995, pp. 195-201.
Stress Induced Changes in Lymphocyte Subpopulations and Associated Cytokines During Whole Body Hyperthermia of 41.8-42.2° C, by O. Ahlers, et al., Eur J Appl Physiol (2005) 95: 298-306.
Heat Shock Proteins and Regulation of Cytokine Expression, by Y. Xie, C.M. Cahill, A. Asea, P.E. Auron, and S.K. Calderwood, Infectious Diseases in Obstetrics and Gynecology 7:26-30 (1999).
Effects of Local and Whole Body Hyperthermia on Immunity by Gian Franco Baronzio, et al., Madame Curie Bioscience Database [Internet], Austin (TX): Landes Bioscience; 2000. [On the Internet at http://www.ncbi.nlm.nih.gov/books/NBK6083/].
Heat Shock Co-Activates Interleukin-8 Transcription, by Ishwar S. Singh, et al., Am J Respir Cell Mol Biol, Aug. 2008; 39(2): 235-242.
Alexander JP, Acott TS; Involvement of the Erk-MAP kinase pathway in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs; Invest Ophthalmol Vis Sci. 2003 Jan; 44(1):164-9.
Wang N, Chintala SK, Fini ME, Schuman JS; Ultrasound activates the TM ELAM-1/IL-1/NF-kappaB response: a potential mechanism for intraocular pressure reduction after phacoemulsification; Invest Ophthalmol Vis Sci. May 2003; 44(5):1977-81.
Bradley JM, Anderssohn AM, Colvis CM, Parshley DE, Zhu XH, Ruddat MS, Samples JR, Acott TS; Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression bylL-1 and TNF; Invest Ophthalmol Vis Sci. 2000; 41:422-430.
Hosseini M, Rose AY, Song K, Bohan C, Alexander JP, Kelley MJ, Acott TS; IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork; Invest Ophthalmol Vis Sci. Apr. 2006; 47(4):1469-76.
Pang IH, Hellberg PE, Fleenor DL, Jacobson N, Clark AF; Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells; Invest Ophthalmol Vis Sci. Aug. 2003; 44(8):3485-93.
Kelley MJ, Rose A, Song K, Lystrup B, Samples JW, Acott TS; p. 38 MAP kinase pathway and stromelvsin regulation in trabecular meshwork cells; Invest Ophthalmol Vis Sci. Jul. 2007; 48(7):3126-37.
Kelley MJ, Rose AY, Song K, Chen Y, Bradley JM, Rookhuizen D, Acott TS; Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork; Invest Ophthalmol Vis Sci. Jun. 2007; 48(6):2634-43.
Written Opinion issued in related Singapore Application No. 200901271-7, provided by the Austrian Patent Office as Search and Examination Authority, with a mailing date of May 19, 2010.
Bradley, John M.B., et al., “Effects of Mechanical Stretching on Trabecular Matrix Metalloproteinases”, Investigative Ophthalmology & Visual Science, Jun. 2001, vol. 42 No. 7.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ultrasonic treatment of glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ultrasonic treatment of glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ultrasonic treatment of glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2777324

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.